TBIO
Translate Bio, Inc. Common Stock
TBIO
TBIO
Delisted
TBIO was delisted on the 13th of September, 2021.
150 hedge funds and large institutions have $1.18B invested in Translate Bio, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 51 increasing their positions, 44 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
80% less call options, than puts
Call options by funds: $2.1M | Put options by funds: $10.7M
Holders
150
Holding in Top 10
3
Calls
$2.1M
Puts
$10.7M
Top Buyers
| 1 | +$35.5M | |
| 2 | +$8.41M | |
| 3 | +$7.19M | |
| 4 |
Barclays
London,
United Kingdom
|
+$2.95M |
| 5 |
BlackRock
New York
|
+$2.72M |
Top Sellers
| 1 | -$36.3M | |
| 2 | -$21.7M | |
| 3 | -$15.5M | |
| 4 |
RI
RTW Investments
New York
|
-$14.1M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$12.8M |